Dodovislactone B is primarily investigated for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in suppressing pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory conditions. Studies suggest it may influence signaling pathways such as NF-κB, which plays a key role in inflammation and cell survival. Due to its natural origin and structural complexity, it is also of interest in drug discovery for developing derivatives with enhanced bioavailability and targeted action. Current applications remain in the preclinical research phase, focusing on in vitro and animal models to evaluate therapeutic efficacy and safety.